B. Riley raised the firm’s price target on Cinemark (CNK) to $35 from $33 and keeps a Neutral rating on the shares following a transfer of coverage. The firm is “generally constructive” on the exhibitor space, saying the sector is underpinned by a strong Hollywood film slate for 2025 and 2026 that should fuel further box office recovery and benefit relevant industry participants. Riley also finds limited tariff risk and a history of movie-going resiliency during periods of economic weakness “to be additional market themes that are supportive of this favorable backdrop.” The firm’s top pick across the group is Imax (IMAX), followed by Marcus (MCS).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
- Cinemark Declares Quarterly Dividend Amid Financial Stability
- Cinemark, D-BOX announce partnership expansion
- Hollywood wanted movies brought back to U.S., but not with tariffs, WSJ says
- Morgan Stanley says tariff on movies could reduce companies’ earnings power
- Tariffs on films may end up hurting industry, says Barclays